GEN ILAC
Gen Ilac is a pharmaceutical company that supplies products used in the treatment of rare diseases and disorders in Neurology, Endocrinology, Nephrology, Oncology, Hematology, and Pediatric branches.
GEN ILAC
Industry:
Medical Pharmaceutical
Founded:
1998-01-01
Status:
Active
Contact:
+90 216 574 06 19
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network GStatic Google Static Content PostalAddress Schema Facebook Domain Insights LocalBusiness Schema Wix SEO_H2
Similar Organizations
Darnitsa
Darnitsa is a pharmaceutical company that specializes in the latest pharmaceutical technologies and progressive discoveries.
Lao Dan
Lao Dan is a pharmaceutical company that specializes in producing formulas based on traditional Chinese herbal remedies.
Zerion Pharma
Zerion Pharma is a pharmaceutical company that aims to transform the pharmaceutical landscape with a new formulation technology.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-09 | Neo Auvra | Gen Ilac investment in Pre Seed Round - Neo Auvra | 1.2 M USD |
| 2021-10-04 | Galventa | Gen Ilac investment in Seed Round - Galventa | 750 K CHF |
More informations about "Gen Ilac"
Contact - GEN
98 Zhandosova Str., Navoi Towers Business Center, Office 401, 050042, Almatı / Kazakistan Phone: +7 (727) 391 10 97 Fax: +7 (727) 391 10 97 E-mail: [email protected]See details»
SULFATEQ and GEN sign definitive collaboration agreement to …
Aug 24, 2021 Groningen, The Netherlands & Ankara, Turkey – Sulfateq BV, an early stage biotech company developing a group of small molecules that maintain mitochondrial health, …See details»
GEN Ä°LAÇ VE SAÄžLIK ÜRÜNLERÄ° SANAYÄ° VE TÄ°CARET A.Åž. - kap.org.tr
GEN Ä°LAÇ VE SAÄžLIK ÜRÜNLERÄ° SANAYÄ° VE TÄ°CARET A.Åž. GENIL : Summary Info. General Info. Corp. Governance. Participation Finance. Financial Info. Notification Search. Head Office …See details»
Abidin Gulmus – Founder and Chairman, Gen Ilaç, Turkey
Nov 14, 2018 We began with Biogen’s singular MS drug, Avonex, but today we have added many more products to our portfolio. Over the years, Gen Ilac has also expanded into other niche disease areas and we signed agreements with several other biotechnology companies. In Turkey, we represent Biogen, Ipsen, Biomarin, Vertex, Orphan Europe, and several others.See details»
SULFATEQ and GEN sign term sheet to develop a therapy for …
Dec 14, 2020 Groningen, The Netherlands & Ankara, Turkey – Sulfateq BV, an early stage biotech company developing a group of small molecules that maintain mitochondrial health, …See details»
Borsa Istanbul
Aug 6, 2021 Message from the CEO Organization Legal Framework Milestones in Borsa Ä°stanbul History International Memberships Corporate Identity Subsidiaries and Affiliates. …See details»
Gen Ilac - Investments, Portfolio & Company Exits - Crunchbase
Gen Ilac has made 2 investments. Their most recent investment was on Feb 9, 2022, when Neo Auvra raised. obfuscated. obfuscated. Unlock for free . Investments. Edit Investments Section. …See details»
Gen Ilac - Crunchbase
Gen Ilac is a pharmaceutical company that supplies products used in the treatment of rare diseases and disorders in Neurology. Search Crunchbase. Start Free Trial . Chrome …See details»
Gen Ilac - VentureRadar
Gen Ilac VentureRadar profile. Find out more about Gen Ilac including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Latest revisions of ILAC P9 and G18 Published
ILAC P9:01/2024 - ILAC Policy for Proficiency Testing and/or Interlaboratory comparisons other than Proficiency Testing This document sets out the policy for accreditation bodies on the use …See details»
KAP
Subsidiaries, Financial Non-Current Assets and Financial Investments Company Title Scope of Activities of CompanySee details»
International Laboratory Accreditation Cooperation - Wikipedia
The International Laboratory Accreditation Cooperation or ILAC started as a conference in 1977 to develop international cooperation for facilitating trade by promoting the acceptance of accredited test and calibration results. In 1996, ILAC became a formal cooperation with a charter to establish a network of mutual recognition agreements among accreditation bodies that would fulfil this aim.See details»
High Demand for IPO of Pharmaceutical Company Aligned with …
We are pleased to note that the impactful investment opportunity is being successfully realised through Gen Ilac, a Turkish pharmaceutical company, which on 28-30 July 2021 collected bids …See details»
ILAC and IAF Merger - eurolab.org
Oct 9, 2024 ILAC and IAF are in the process of merging into a new organization, the Global Accreditation Cooperation (GLOBAC), that will replace ILAC and IAF in 2025.. The historic first …See details»
Revised G18 Document Published International Laboratory ... - ILAC
Dec 21, 2021 This version is a major revision of ILAC-G18:04/2010 as a result of the publication of ISO/IEC 17011:2017 as well as an extension of the scope of the document to include …See details»
Gen Ilac - Updates, News, Events, Signals & Triggers - Crunchbase
Gen Ilac is a pharmaceutical company that supplies products used in the treatment of rare diseases and disorders in Neurology. Search Crunchbase. Start Free Trial . Chrome …See details»
ILAC Organisation Chart - ILAC – ILAC Live Site
ILAC Organisation Chart. ILAC organisation chart as at November 2019.See details»
Message from the Chair - ilac.org
ILAC 2024 Annual Summary and GLOBAC Establishment Activities As we close the year 2024, I extend my deepest gratitude to our member organizations, stakeholders, and international …See details»
ILAC and IAF are Merging to form GLOBAC
Nov 4, 2024 ILAC and IAF are Merging to form GLOBAC. There is an important development in the global accreditation landscape. At their annual meetings in October 2024, the International …See details»